ANALYSIS OF METASTASIS-FREE SURVIVAL IN PATIENTS WITH SMALL CHOROID MELANOMA DEPENDING ON THE TYPE OF PRIMARY TUMOR TREATMENT

Autor: L. V. Naumenko, S. A. Krasny, K. P. Zhylayeva, A. A. Evmenenko, I. Y. Zherko

Publikováno v: Сибирский онкологический журнал, Vol 20, Iss 5, Pp 108-114 (2021)

Background. There is no unified approach to the management of patients with small choroid melanoma (CM) (thickness up to 3 mm, base diameter up to 10 mm). The study of the development of metastases in these patients is of great significance for choos

Externí odkaz: https://doaj.org/article/38632f95c07f4da8b41afbba9b52669c

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy – Observational prospective single institution analysis

Autor: Iva Staniczková Zambo, Michal Mahdal, Jaroslav Štěrba, Michal Kýr, Peter Múdry, Tomáš Tomáš, Ondřej Rohleder, Marta Ježová

Publikováno v: Journal of Bone Oncology
Journal of Bone Oncology, Vol 28, Iss, Pp 100362-(2021)

Highlights • A report on the best treatment results on an osteosarcoma cohort. • There has been a lack of improvement in osteosarcoma treatment for the last four decades. • Mifamurtide is the only new drug against osteosarcoma licensed by the E

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c118ffa5edf04ec7cbadbdbcdc345ac3
http://europepmc.org/articles/PMC8080518

Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy - Observational prospective single institution analysis.

Autor: Múdry P; Department of Paediatric Oncology, University Hospital Brno and School of Medicine, Masaryk University, Cernopolni 9, Brno 613 00, Czech Republic.; International Clinical Research Centre, St. Anne's University Hospital Brno, Pekarska 53, Brno 656 91, Czech Republic., Kýr M; Department of Paediatric Oncology, University Hospital Brno and School of Medicine, Masaryk University, Cernopolni 9, Brno 613 00, Czech Republic.; International Clinical Research Centre, St. Anne's University Hospital Brno, Pekarska 53, Brno 656 91, Czech Republic., Rohleder O; Department of Paediatric Oncology, University Hospital Brno and School of Medicine, Masaryk University, Cernopolni 9, Brno 613 00, Czech Republic.; International Clinical Research Centre, St. Anne's University Hospital Brno, Pekarska 53, Brno 656 91, Czech Republic., Mahdal M; 1 Department of Orthopaedics, St. Annés University Hospital Brno and School of Medicine, Masaryk University, Pekarska 53, Brno 613 00, Czech Republic., Staniczková Zambo I; 1 Department of Pathology, St. Anne's University Hospital Brno and School of Medicine, Masaryk University, Pekarska 53, Brno 613 00, Czech Republic., Ježová M; Department of Pathology, University Hospital Brno and School of Medicine, Masaryk University, Jihlavska 20, Brno 625 00, Czech Republic., Tomáš T; 1 Department of Orthopaedics, St. Annés University Hospital Brno and School of Medicine, Masaryk University, Pekarska 53, Brno 613 00, Czech Republic., Štěrba J; Department of Paediatric Oncology, University Hospital Brno and School of Medicine, Masaryk University, Cernopolni 9, Brno 613 00, Czech Republic.; International Clinical Research Centre, St. Anne's University Hospital Brno, Pekarska 53, Brno 656 91, Czech Republic.

Publikováno v: Journal of bone oncology [J Bone Oncol] 2021 Apr 07; Vol. 28, pp. 100362. Date of Electronic Publication: 2021 Apr 07 (Print Publication: 2021).